IP Library Granted Patent US 8,139,715
Granted Patent B2
US 8,139,715 · App. 12/932,076 · Granted Mar 20, 2012

Method and composition for crystallizing G protein-coupled receptors

Assignee: The Board of Trustees of the Leland Stanford Junior University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,139,715
App. No.
12/932,076
Granted
Mar 20, 2012
Kind
B2
Abstract

Certain embodiments provide a method for crystallizing a GPCR. The method may employ a fusion protein comprising: a) a first portion of a G-protein coupled receptor (GPCR), where the first portion comprises the TM1, TM2, TM3, TM4 and TM5 regions of the GPCR; b) a stable, folded protein insertion; and c) a second portion of the GPCR, where the second portion comprises the TM6 and TM7 regions of the GPCR.

Claims (28)

1. A method for obtaining an X-ray diffraction pattern, comprising:

a) exposing a crystal of a GPCR fusion protein to a source of X-rays, wherein said GPCR fusion protein comprises, from N-terminus to C-terminus:

i. a first portion of a G-protein coupled receptor (GPCR), wherein said first portion comprises TM1, TM2, TM3, TM4 and TM5 regions of said GPCR;

ii. a domain comprising the amino acid sequence of a lysozyme; and

iii. a second portion of said GPCR, wherein said second portion comprises TM6 and TM7 regions of said GPCR; and

b) collecting an X-ray diffraction pattern for said crystal.

2. The method of claim 1 , further comprising resolving said X-ray diffraction pattern to provide a set of atomic coordinates for said GPCR.

3. The method of claim 2 , further comprising modeling said atomic coordinates to provide a structural model of said GPCR.

4. The method of claim 1 , wherein said domain comprises an amino acid sequence having at least 80% identity to the amino acid sequence of a wild-type lysozyme.

5. The method of claim 1 , wherein said domain comprises an amino acid sequence having at least 95% identity to a wild-type lysozyme.

6. The method of claim 1 , wherein said domain comprises an amino acid sequence that is at least 95% identical to the amino acid sequence of T4 lysozyme.

7. The method of claim 1 , wherein said first and second portions of said GPCR comprise the amino acid sequence of a naturally occurring GPCR.

8. The method of claim 1 , wherein said first and second portions of said GPCR comprise the amino acid sequence of a non-naturally occurring GPCR.

9. The method of claim 1 , wherein the amino acid sequence of said first and second portions of said GPCR are least 80% identical to amino acid sequences of a wild type GPCR.

10. The method of claim 1 , wherein said a GPCR is selected from the group consisting of: a receptor for a biogenic amine, a dopamine receptor, a seratonin receptor, an adrenergic receptor, aβ2-adrenergic receptor, a melanocortin receptor subtype 4, a ghrelin receptor, a metabotropic glutamate receptor and a chemokine receptor.

11. The method of claim 1 , wherein said domain is in the range of from 100 to 200 amino acids in length.

12. A method for obtaining an X-ray diffraction pattern, comprising:

a) exposing a crystal of an polypeptide to a source of X-rays, wherein said polypeptide comprises, from N-terminus to C-terminus:

i. a first portion of a G-protein coupled receptor (GPCR), wherein said first portion comprises the amino acid sequence that is N-terminal to the 1C3 loop of said GPCR;

ii. a domain comprising the amino acid sequence of a lysozyme; and

iii. a second portion of said GPCR, wherein said second portion comprises the amino acid sequence that is C-terminal to the IC3 loop of said GPCR; and

b) collecting an X-ray diffraction pattern for said crystal.

13. The method of claim 12 , wherein said domain spaces the C-terminal end of the first portion of said GPCR and the N-terminal end of the second portion of said GPCR so that the closest alpha carbon atoms at said C-terminal end and said N-terminal end are spaced by a distance of in the range of 6 Å to 16 Å.

14. The method of claim 12 , wherein the amino acid sequence of said first and second portions of said GPCR are least 80% identical to amino acid sequences of a wild type GPCR.

15. The method of claim 12 , wherein said domain comprises an amino acid sequence having at least 80% identity to the amino acid sequence of a wild-type lysozyme.

16. A method for obtaining an X-ray diffraction pattern, comprising:

a) exposing a crystal of a GPCR to X-rays, wherein said GPCR comprises an IC3 loop containing a substitution that comprises the amino acid sequence of a lysozyme; and,

b) collecting an X-ray diffraction pattern for said crystal.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2011
From: KOBILKA, BRIAN; ROSENBAUM, DANIEL
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 026532/0333 →
CONFIRMATORY LICENSE Recorded Apr 15, 2011
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026133/0111 →
Continuity (4)
Continuation 12803328 · Jun 23, 2010
Continuation 12288097 · Oct 15, 2008
Provisional Application 61000176 · Oct 17, 2007
Related Publication 20110164731A1 · Jul 7, 2011